Role of inhaled human insulin in the management of Type 1 and 2 diabetes

Authors: Briscoe, Vanessa J; Davis, Stephen N

Source: Expert Review of Endocrinology and Metabolism, Volume 1, Number 4, July 2006 , pp. 479-488(10)

Publisher: Expert Reviews

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Inhaled human insulin (Exubera^®) has been approved by the FDA and other regulatory bodies for treatment in Type 1 and 2 diabetes in the USA. It is the first alternative to injectable insulin since the discovery of the insulin compound to treat diabetes. This article will review results of recent clinical studies that support the therapeutic efficacy and safety of inhalable insulin for use in patients with diabetes. The pharmacological profile of inhaled insulin with particular reference to inhaled human insulin and the potential to influence diabetes care is also discussed.

Keywords: diabetes Type 1; diabetes Type 2; exubera; inhaled insulin

Document Type: Research article

DOI: 10.1586/17446651.1.4.479

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$73.00 plus tax Refund Policy